Rise Therapeutics is focused on developing targeted immunological-based biologics using a unique and proprietary oral delivery platform.
Rise Therapeutics is focused on developing targeted immunological-based biologics using a unique and proprietary oral delivery platform. Rise leverages its target discovery expertise to understand microbiome gut biology as it relates to regulation of immune function.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 5, 2017 | Seed | $200K | 1 | TEDCO | — | Detail |